Health Stocks in News: Eli Lilly and Co (NYSE:LLY), Zogenix (NASDAQ:ZGNX), GlaxoSmithKline (NYSE:GSK), Novartis (NYSE:NVS)

Posted by on Mar 10, 2014

Eli Lilly and Company’s (NYSE:LLY) shares were up 0.8% after the company announced encouraging data from the sixth phase III AWARD (Assessment of Weekly Administration of LY2189265 in Diabetes) study on its diabetes candidate, dulaglutide. Overall, the stock price has increased 1.1% on the news. Eli Lilly and Co (NYSE:LLY) stock opened at $58.89 in last session, and closed at $58.59, while the day range of Eli Lilly and Co (NYSE:LLY) stock is $58.15 – $59.08. The stock showed a positive weekly performance of -1.71%.

Zogenix, Inc. (NASDAQ:ZGNX) on Mar. 5 reported financial results for the fourth quarter and full year ended December 31, 2013. Zogenix, Inc. (NASDAQ:ZGNX) stock opened at $3.98 in last session, and closed at $4.04 by gaining 5.21%. The 52 week range of $1.25 – $5.19. Company’s market capitalization is $422.92 million.

U.K. Drug Company GlaxoSmithKline PLC (ADR) (NYSE:GSK) and Theravance, Inc. (THRX) said a European Union agency recommended that their new treatment for lung disease be approved for sale. GlaxoSmithKline plc (ADR) (NYSE:GSK) stock decreased -0.57% and finished the last session at $55.53. The EPS of the stock remained 3.71. Company’s market capitalization is $133.22 billion.

A new Novartis AG (ADR) (NYSE:NVS) drug, ruxolitinib, which is being marketed as Jakavi, was successful in late-stage trials, Reuters reports. The drug has the potential to become a blockbuster for Novartis, with sales estimated at more than $1 billion annually. Novartis AG (ADR) (NYSE:NVS) stock opened the session at $83.70, and closed the session at $83.14. The 52 week range of the Novartis AG (ADR) (NYSE:NVS) stock remained $67.67 – $84.37 and the day range was $82.87 – $83.77.

Leave a Reply

Your email address will not be published. Required fields are marked *